The Canadian Nephrology Trials Network (CNTN) was created to support and strengthen collaboration between kidney researchers and patient partners eager to learn share their lived experience to shape research.
CNTN aims to improve the relevance, number, and quality of nephrology clinical trials in Canada, as well as researchers’ ability to conduct multi-centre trials. The network also aims to help integrate patient priorities into care and practice through increased patient involvement, peer review, engagement, and training.
This past year, the CNTN has continued to support peer review and feedback of trials through the CNTN Scientific Operations Committee, which consists of researchers and patient partners. As well, the network is in the process of developing a Patient Partners in CNTN Peer Review module to help demonstrate the value of including patients in the peer review process, which is anticipated to launch Spring 2023.
This year the network also debuted the CNTN Spotlight Podcast, which features engaging conversations about clinically relevant research. The podcast gives researchers an opportunity to highlight their research and for patient partners to speak about their roles within the network.
It is important to note that the evolution of clinical research in Canada will bring new opportunities for capacity building. Can-SOLVE CKD is excited to be at the forefront of this endeavour, bringing together researchers, patient partners, policy-makers, healthcare administrators and other stakeholders. As a team, we are honoured to be making a positive impact on the kidney research landscape in Canada.